Clinical and Economic Aspects of <i>KRAS </i>Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer PatientsRobert Königsberg, Christian Dittrich, Tanja Steininger et al.|Oncology|2011Cited by 13
Front & Back MatterChristian Dittrich, Ken Kato, Robert Königsberg et al.|Oncology|2011Cited by 0